Online tool to guide decisions for BRCA1/2 mutation carriers.

  title={Online tool to guide decisions for BRCA1/2 mutation carriers.},
  author={Allison W. Kurian and Diego F. Mu{\~n}oz and Peter Rust and Elizabeth A. Schackmann and Michael J A Smith and Lauren Clarke and Meredith A. Mills and Sylvia K Plevritis},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  volume={30 5},
PURPOSE Women with BRCA1 or BRCA2 (BRCA1/2) mutations must choose between prophylactic surgeries and screening to manage their high risks of breast and ovarian cancer, comparing options in terms of cancer incidence, survival, and quality of life. A clinical decision tool could guide these complex choices. METHODS We built a Monte Carlo model for BRCA1/2 mutation carriers, simulating breast screening with annual mammography plus magnetic resonance imaging (MRI) from ages 25 to 69 years and… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 8 times. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 35 extracted citations

A MDP Model for Breast and Ovarian Cancer Intervention Strategies for BRCA1/2 Mutation Carriers

IEEE Journal of Biomedical and Health Informatics • 2015
View 8 Excerpts
Highly Influenced

A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research • 2017
View 2 Excerpts

Similar Papers

Loading similar papers…